• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Avalanche Biotechnologies, Inc. (AAVL)

    -NasdaqGM
    40.52 Up 1.11(2.82%) 4:00PM EDT
    |After Hours : 40.52 Down 0.00 (0.01%) 4:39PM EDT
    Add to Portfolio
    Prev Close:39.41
    Open:39.27
    Bid:33.00 x 100
    Ask:58.54 x 200
    1y Target Est:51.83
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:39.05 - 41.15
    52wk Range:22.00 - 62.48
    Volume:259,821
    Avg Vol (3m):395,189
    Market Cap:865.51M
    P/E (ttm):N/A
    EPS (ttm):-2.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AAVL

    Comparison

    Symbol% ChgMkt Cap
    AAVLUp 2.82%865.51M
    REGNDown 1.81%46.00B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,471.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.89
    Quarterly EPS Est (Mar-15) :-0.40
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Avalanche Biotechnologies, Inc., a clinical-stage biotechnology company, focuses on discovering and developing novel gene therapies for the treatment of ophthalmic diseases based on its Ocular BioFactory platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback